Skip to content
Open Data Finder

Search results for sub

FiltersOpen Government Canada

5,406 datasets for “sub”

  1. Open Government Canada

    Drug and Health Product Submissions Under Review (SUR): New drug submissions completed

    Health Canada | Santé CanadaUpdated 1 Sept 2023

    Submissions formerly under review: New drug submissions

    • HTML
  2. Open Government Canada

    Drug and Health Product Submissions Under Review (SUR): Supplemental submissions completed

    Health Canada | Santé CanadaUpdated 1 Sept 2023

    Submissions formerly under review: Supplemental new drug submissions for new uses

    • HTML
  3. Open Government Canada

    Drug and Health Product Submissions Under Review (SUR): New drug submissions under review

    Health Canada | Santé CanadaUpdated 1 Sept 2023

    Submissions currently under review: New drug submissions

    • HTML
  4. Open Government Canada

    Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions

    Health Canada | Santé CanadaUpdated 3 Sept 2023

    The attached policy has been developed to provide for the filing of Supplemental New Drug Submissions, Supplemental Abbreviated …

    • HTML
  5. Open Government Canada

    Message to Industry Subject: Milk Protein Substances Tariff Rate Quota (TRQ)

    Global Affairs Canada | Affaires mondiales CanadaUpdated 8 Oct 2025

    Message to Industry Subject: Milk Protein Substances Tariff Rate Quota (TRQ)

    • HTML
  6. Open Government Canada

    Submitting risk management plans draft guidance document: Procedures to submit

    Health Canada | Santé CanadaUpdated 4 Apr 2024

    Information on risk management plan submissions for drugs including when to file, considerations, requirements, and compliance.

    • HTML
  7. Open Government Canada

    Chemicals Management Plan approach for subset of substances prioritized during categorization

    Health Canada | Santé CanadaUpdated 26 Aug 2022

    In February 2015, the Government of Canada published a Final Approach for a Subset of Substances Prioritized during …

    • HTML
  8. Open Government Canada

    Petroleum substances

    Health Canada | Santé CanadaUpdated 30 Aug 2022

    There are approximately 210 remaining priority petroleum substances that have been identified as priority substances to be addressed.

    • HTML
  9. Open Government Canada

    Draft guidance on management of rolling reviews for drug submissions: Filing a submission

    Health Canada | Santé CanadaUpdated 1 Sept 2023

    Data or information provided after the submission is filed in accordance with the notice of rolling review status …

    • HTML
  10. Open Government Canada

    Prescription management by pharmacists with controlled substances under the Controlled Drugs and Substances Act and its regulations

    Health Canada | Santé CanadaUpdated 25 Mar 2021

    Health Canada's interpretation of controlled substances prescribing activities pharmacists can perform under the Controlled Drugs and Substances …

    • HTML
  11. Open Government Canada

    Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada

    Health Canada | Santé CanadaUpdated 1 Feb 2023

    … are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic.

    • HTML
  12. Open Government Canada

    Methylenediphenyl diisocyanate (MDI) substances

    Health Canada | Santé CanadaUpdated 30 Aug 2022

    Learn about methylenediphenyl diisocyanate (MDI) substances.

    • HTML
  13. Open Government Canada

    Milk Protein Substances Imports

    Global Affairs Canada | Affaires mondiales CanadaUpdated 9 Oct 2025

    Milk Protein Substances Imports.

    • HTML
  14. Open Government Canada

    Substituted Alkyl Imidazolines Group

    Health Canada | Santé CanadaUpdated 31 Jul 2023

    These substances were identified for action under the Chemicals Management Plan (CMP). The screening assessment focuses on 4 …

    • HTML
  15. Open Government Canada

    Generic submissions under review

    Health Canada | Santé CanadaUpdated 17 Sept 2020

    How to access a list of generic drug submissions currently under review.

    • HTML
  16. Open Government Canada

    Subsection 56(1) Class Exemption for the Person in Charge of a Hospital and/or a Pharmacist who Supplies Controlled Substances to a Community Health Facility

    Health Canada | Santé CanadaUpdated 1 Feb 2023

    Subsection 56(1) Class Exemption for the Person in Charge of a Hospital and/or a Pharmacist who …

    • HTML
  17. Open Government Canada

    Preventing problematic substance use through positive youth development

    Public Health Agency of Canada | Agence de la santé publique du CanadaUpdated 11 Jul 2019

    There are effective universal school-based programs that reduce youths' risk of problematic substance use by supporting positive …

    • HTML
    • PDF
  18. Open Government Canada

    Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic

    Health Canada | Santé CanadaUpdated 6 Jan 2021

    … are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic.

    • HTML
  19. Open Government Canada

    Submission 'Class'

    Health Canada | Santé CanadaUpdated 17 Sept 2020

    For eligible submissions accepted into review on or after October 1, 2018, the submission 'class' added to the …

    • HTML
  20. Open Government Canada

    Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances - ICH Topic Q6A

    Health Canada | Santé CanadaUpdated 29 Dec 2023

    … Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

    • HTML
“sub” datasets · Open Data Finder